Riluzole

In the US, Riluzole (riluzole systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Amyotrophic Lateral Sclerosis and Obsessive Compulsive Disorder.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N07XX02

CAS registry number (Chemical Abstracts Service)

0001744-22-5

Chemical Formula

C8-H5-F3-N2-O-S

Molecular Weight

234

Therapeutic Categories

Glutamate antagonist

Neuroprotective agent

Chemical Name

2-Benzothiazolamine, 6-(trifluoromethoxy)-

Foreign Names

  • Riluzolum (Latin)
  • Riluzol (German)
  • Riluzole (French)
  • Riluzol (Spanish)

Generic Names

  • Riluzole (OS: BAN, DCF, USAN)
  • PK 26124 (IS)
  • RP 54274 (IS: RhônePoulencR)
  • Riluzole (PH: USP 34)

Brand Names

  • Fanizan
    Actavis, Estonia
  • Laidec
    Sun Pro, Taiwan
  • Lizolorol
    Actavis, Estonia
  • Lizorolol
    ratiopharm, Netherlands
  • Rilustad
    STADA, Estonia
  • Rilutek
    Aventis, Poland; Aventis, Slovenia; Aventis Pharma, Latvia; Aventis Pharma, Norway; Sanofi Aventis, Brazil; Sanofi Aventis, China; Sanofi Aventis, Spain; Sanofi Aventis, Japan; Sanofi Winthrop, Serbia; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Hungary; Sanofi-Aventis, Ireland; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, South Korea; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Mexico; Sanofi-Aventis, Netherlands; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Peru; Sanofi-Aventis, Portugal; Sanofi-Aventis, Romania; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan
  • Riluzol 1A Pharma
    1A Pharma, Netherlands
  • Riluzol Actavis
    Actavis, Netherlands
  • Riluzol CF
    Centrafarm, Netherlands
  • Riluzol Generis
    Generis, Portugal
  • Riluzol Hexal
    Hexal, Netherlands
  • Riluzol Mylan
    Mylan, Netherlands
  • Riluzol PMCS
    PRO.MED.CS, Netherlands
  • Riluzol Sandoz
    Sandoz, Netherlands
  • Riluzol Sun
    Sun Pharma, Netherlands
  • Riluzol Teva
    Teva, Netherlands
  • Riluzole Actavis
    Actavis, Estonia; Actavis, Lithuania; Actavis, Latvia
  • Riluzole ESP Pharma
    ESP Pharma, Estonia
  • Riluzole STADA
    STADA, Estonia
  • Riluzole Teva
    Teva, Estonia
  • Riluzole
    Impax, United States
  • Riluzole-Nhwa Pharm
    Nhwa, China
  • Rimipole
    Actavis, Estonia
  • Sclefic
    Actavis, Bulgaria; Actavis, Czech Republic; Actavis, Estonia; Actavis, Malta; Actavis, Slovenia
  • Xie Yi Li
    Lunan Pharm, China
  • Zolerilis
    Actavis, Estonia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web5)